Last Update 27 Apr 26

CGY: Defence Partnerships And Credit Capacity Expansion Will Drive Future Upside

Analysts have lifted their average Calian Group price target toward the CA$78 to CA$80 range, reflecting updated assumptions for discount rate, revenue growth, profit margin and future P/E, alongside recent target increases from multiple research shops.

Analyst Commentary

Recent Street research on Calian Group has centered on refreshed price targets in the CA$78 to CA$80 range and a generally constructive stance on the shares. The updates focus on how current valuation lines up with execution risks and the company’s longer term growth assumptions.

Bullish Takeaways

Bullish analysts are setting price targets between CA$78 and CA$80, which signals confidence that the current share price does not fully reflect their assumptions on revenue growth, margin profile and future P/E.
The shift from earlier targets in the CA$60s suggests these analysts now see a stronger risk or reward trade off as their models are recalibrated for updated discount rates and earnings power.
An initiation with a positive stance adds another supportive voice, which some readers may view as validation that the equity story has gained traction across a wider group of institutions.
Combined, the higher targets and supportive ratings point to a view that, if the company delivers on its growth and profitability assumptions, there is room for value creation relative to the analysts’ fair value estimates.

Bearish Takeaways

Even with higher targets, analysts are still relying on a set of assumptions about revenue growth, margin levels and future P/E that may not play out as expected, which leaves room for disappointment if execution slips.
The clustering of targets in a fairly tight CA$78 to CA$80 band suggests limited upside in these models beyond that range, so any setback on growth or profitability could push their fair value views lower.
Readers should keep in mind that these targets are model based estimates, not guarantees, and they can be revised if market conditions, discount rates or company specific factors change.
A focus on bullish ratings can create a one sided picture, so it is important to weigh these target moves against the inherent operational and forecast risks that all equity research carries.

What's in the News

Calian exercised CA$75 million of its accordion feature, lifting total committed capacity under its credit facility to CA$275 million, within an overall facility capacity of CA$350 million and net debt to adjusted EBITDA of 1.2x as of December 31, 2025, to support acquisitions and internal investment (Key Developments).
The company is seeking acquisitions, with management highlighting lender support and a reported backlog of CA$1,400 million, alongside a focus on defence, space, healthcare and critical infrastructure markets (Key Developments).
Calian and Tessellate Robotics announced a collaboration under Calian VENTURES to integrate and test autonomous navigation technologies for defence use in complex environments, including Canada’s Arctic, with initial field testing and deployment planned during Operation Nanook (Key Developments).
Calian and ADGA Group Consultants agreed to a three year collaboration to pursue next generation integrated land training and simulation solutions for the Canadian Army, aligned with Canada’s Defence Industrial Strategy and C5ISRT concepts (Key Developments).
Will Majic was appointed acting Chief Financial Officer effective February 23, 2026, after holding several senior finance roles at Calian and contributing to acquisitions, equity financings and the establishment of a CA$350 million syndicated credit facility (Key Developments).

Valuation Changes

Fair Value: CA$84.75 is unchanged, indicating no shift in the core valuation output of the model.
Discount Rate: Has risen slightly from 6.54% to 6.57%, a small adjustment that can modestly affect present value estimates.
Revenue Growth: Holds essentially stable at about 7.51%, with only a minimal numerical change in the latest update.
Net Profit Margin: Remains roughly flat at about 2.96%, with an immaterial adjustment in the updated inputs.
Future P/E: Has inched higher from 34.97x to 34.99x, reflecting a very small tweak in the assumed earnings multiple applied in the model.

7 views

Key Takeaways

Strong growth in defense, space, and cybersecurity positions Calian to capitalize on expanding government budgets and heightened digital infrastructure needs.
Targeted acquisitions and recurring healthcare contracts support margin expansion, diversification, and increased shareholder value through enhanced earnings and buybacks.
Reliance on defense contracts, acquisition risks, segment underperformance, rising competition, and regulatory pressures threaten revenue stability, margins, and long-term profitability.

Catalysts

About Calian Group

Provides business products and solutions in Canada and internationally.What are the underlying business or industry changes driving this perspective?

Substantial recent growth in the defense business (now 50% of revenues and up 19% YoY) alongside a $1.5 billion backlog and a >$1 billion deal pipeline in Europe positions Calian to benefit from rising global defense spending-especially as public sector budgets in Canada and Europe expand in response to geopolitical instability-supporting strong future revenue and earnings growth.
Intensifying investments in space and cybersecurity solutions-reinforced by increasing digitalization of critical infrastructure and heightened cyber threats-provide Calian with opportunities for premium, differentiated offerings, which should improve margin mix and drive robust EBITDA growth as these segments expand.
Ongoing healthcare contract expansions (e.g., AMS acquisition and expanded HCPR contract), as well as the sustained need for healthcare and telehealth solutions driven by aging populations and government recruitment targets, underpin stable and recurring high-margin revenue growth for Calian's health business.
Strategic M&A focus on high-margin, synergistic targets in defense, healthcare, and advanced tech bolsters diversification, accelerates revenue growth, and broadens Calian's cross-solution capabilities, supporting improved net margins and further enhancing the long-term earnings profile.
Accelerated buyback activity (5% of shares YTD, targeting 6% for FY25), compounded by strong free cash flow generation and a robust balance sheet, will likely boost EPS and shareholder value as recurring revenue and improved segment performance materialize.

Calian Group Earnings and Revenue Growth

Calian Group Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Calian Group's revenue will grow by 7.5% annually over the next 3 years.
Analysts assume that profit margins will shrink from 3.3% today to 3.0% in 3 years time.
Analysts expect earnings to reach CA$29.3 million (and earnings per share of CA$0.23) by about April 2029, up from CA$26.6 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 37.2x on those 2029 earnings, up from 29.9x today. This future PE is greater than the current PE for the CA Commercial Services industry at 31.8x.
Analysts expect the number of shares outstanding to decline by 2.36% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 6.57%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Persistent underperformance in the ITCS segment-including ongoing 10% revenue decline, management turnover, and delayed recovery-could signal structural challenges or market share loss, potentially eroding overall revenue and compressing margins if not reversed.
Heavy reliance on government defense budgets (notably in Canada and Europe, where defense now contributes 50% of revenues) creates elevated exposure to political risk, procurement delays, or abrupt budget shifts, which could lead to revenue volatility and unpredictable contract timing.
Aggressive expansion via acquisitions, while fueling growth, heightens integration risk and raises goodwill and debt levels; future acquisition missteps or rising valuation multiples for targets could trigger impairment charges and impact net earnings.
Increased global competition in defense, IT, and healthcare services from both multinational primes and niche specialists may drive down average contract margins, dilute differentiation, and force Calian to spend more on sales, marketing, or hiring, thereby pressuring EBITDA and operating profits.
Rising compliance costs from security, privacy, and ESG regulations, alongside talent shortages and wage inflation in specialized fields like cyber and engineering, risk inflating operating expenses and could constrain net margins and free cash flow over the long term.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of CA$84.75 for Calian Group based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$94.0, and the most bearish reporting a price target of just CA$76.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be CA$990.4 million, earnings will come to CA$29.3 million, and it would be trading on a PE ratio of 37.2x, assuming you use a discount rate of 6.6%.
Given the current share price of CA$69.8, the analyst price target of CA$84.75 is 17.6% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Calian Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Defense Healthcare And Cyber Opportunities Will Transform Future Markets